Navigation Links
'Spot' Shortages of Flu Vaccine, Tamiflu Reported, FDA Head Says
Date:1/15/2013

TUESDAY, Jan. 15 (HealthDay News) -- Sporadic shortages of both the flu vaccine and the flu treatment Tamiflu are being reported, as this year's intense flu season continues, according to a top U.S. health official.

"We have received reports that some consumers have found spot shortages of the vaccine," Dr. Margaret Hamburg, commissioner of the U.S. Food and Drug Administration, said Monday on her blog on the agency's website.

Hamburg said that the agency is "monitoring this situation and will update you at our website and at www.flu.gov."

So far, more than 128 million doses of flu vaccine have been distributed, Hamburg said, but not all the doses have been administered to people yet.

She said that people who already have the flu may also be experiencing local shortages of Tamiflu, a drug that can help treat influenza.

"We do anticipate intermittent, temporary shortages of the oral suspension form of Tamiflu -- the liquid version often prescribed for children -- for the remainder of the flu season. However, FDA is working with the manufacturer to increase supply," she said.

Hamburg also noted that "FDA-approved instructions on the label provide directions for pharmacists on how to compound a liquid form of Tamiflu from Tamiflu capsules."

Flu season typically peaks in January or February but can extend as late as May. This flu season is turning out to be more severe than last year's, many experts say.

Officials at the U.S. Centers for Disease Control and Prevention said on Friday that 47 states were reporting widespread influenza activity, although flu case numbers were beginning to subside in some regions, especially in the Southeast where flu showed up first.

It's still not too late to get the flu shot to help protect you, Hamburg stressed. She noted that it takes about two weeks after vaccination for your body to develop an immune response to provide protection against the flu.

"The flu vaccine is moderately effective this year, and people who are vaccinated have about a 60 percent lower risk of getting the flu compared to someone who is not vaccinated," Dr. Edward Belongia, an epidemiologist at the CDC, said in a statement released Friday.

People who want to get vaccinated can visit flu.gov, click on the "Flu Vaccine Finder," enter their zip code and find a list of clinics, supermarkets, pharmacies and other flu vaccination locations in their neighborhoods.

But before you go to one of the locations, call ahead to confirm that they have the flu vaccine, Hamburg advised.

According to recommendations from the CDC, all adults and children who are at least 6 months old should receive a flu vaccination each year. The best time to get vaccinated is in the fall.

More information

The U.S. Centers for Disease Control and Prevention has more about the flu and flu vaccine.

-- Robert Preidt

SOURCE: blog, Dr. Margaret Hamburg, Commissioner, U.S. Food and Drug Administration, Jan. 15, 2013


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Mesothelioma Victims Center Is Now Open Every Weekend to Make Certain Victims Of Mesothelioma or their Family Members Get to the Best Mesothelioma Law Firms-On The Spot
2. Surgical technique spots cancer invasion with fluorescence
3. Pap Test Could Spot Some Ovarian Cancers, Study Finds
4. 9W LED Spot Delivering 550lm from Zhongtian Lighting
5. 4W LED Spot Light [ZT-M16G10-411A] is Released by Zhongtian Lighting
6. Brain Scans Might Help Spot Risk for Bipolar Disorder
7. 5W LED Spot Light [ZT-M16E11-511H] from Zhongtian Lighting
8. For Psychiatric Patients, Cancer Is Often Spotted Too Late
9. Why are kids in asthma hotspots in NYC more likely to visit the ER? Exercise may be a factor
10. WeightWise Infographic Spotlights Twinkies Ingredients’ Non-Food Uses
11. Stem cell sticky spots recreated by scientists
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
'Spot' Shortages of Flu Vaccine, Tamiflu Reported, FDA Head Says
(Date:2/20/2017)... ... February 20, 2017 , ... ... self-service technology that runs on the Posiflex XT-series of touch screen terminals. Both ... HIMSS17 in Orlando, Florida. The terminal provider Posiflex is helping to bridge ...
(Date:2/20/2017)... , ... February 20, 2017 , ... ... welcomes you to stop by for a visit this week at HIMSS 2017 ... and executives from around the globe. Sensogram will be featured in the conference’s ...
(Date:2/20/2017)... Houston, TX (PRWEB) , ... February 20, 2017 ... ... he is now offering a full range of emergency dental care at his ... teeth and gums. When patients experience dental emergencies, they are at risk for ...
(Date:2/20/2017)... Orlando, FL (PRWEB) , ... February 20, 2017 ... ... company for eye care providers and health plan partners, announced during the 2017 ... the organization’s success enhancing care coordination for diabetic patients and integrating eye ...
(Date:2/19/2017)... (PRWEB) , ... February 19, 2017 , ... Braun Industries ... JEMS Conference & Exposition, the event will take place February 23-25, 2017 at the ... will be in Booth #909 with three new ambulances on display. ...
Breaking Medicine News(10 mins):
(Date:2/17/2017)... , Feb. 17, 2017   FormFast , ... announced a new partnership with Engage , one ... United States . FormFast will serve as the ... Engage,s implementations with MEDITECH .  ... essential functionality to complement and enhance the electronic health ...
(Date:2/17/2017)...  BioDigital, Inc., creators of the BioDigital Human ... body mapping technology with eClinicalWorks, a privately held ... be used to capture and present dermatology exam ... body. BioDigital pilots show using a body to ... the precision of clinical annotations compared to standard ...
(Date:2/17/2017)... YORK , Feb. 17, 2017  Noble Capital ... on ESSA Pharma Inc. (Nasdaq: EPIX ). ... Research, Kumar Raja , PhD. ESSA ... for castration resistant prostate cancer (CRPC). Its lead compound ... blocks the amino-terminal domain of the androgen receptor, thereby ...
Breaking Medicine Technology: